Terms: = Sarcomas AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L AND Clinical Outcome
25 results:
1. sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype.
Chang HY; Dermawan J; Sharma A; Dickson B; Turashvili G; Torrence D; Nucci M; Chiang S; Oliva E; Kirchner M; Stenzinger A; Mechtersheimer G; Antonescu C
Mod Pathol; 2024 Feb; 37(2):100402. PubMed ID: 38141829
[TBL] [Abstract] [Full Text] [Related]
2. Medium levels of transcription and replication related chromosomal instability are associated with poor clinical outcome.
Benhaddou A; Gaston L; Pérot G; Desplat N; Leroy L; Le Guellec S; Ben Haddou M; Rochaix P; Valentin T; Ferron G; Chevreau C; Bui B; Stoeckle E; Le Cesne A; Piperno-Neumann S; Collin F; Firmin N; De Pinieux G; Coindre JM; Blay JY; Chibon F
Sci Rep; 2021 Dec; 11(1):23429. PubMed ID: 34873180
[TBL] [Abstract] [Full Text] [Related]
3. Adamantinoma-like Variant of Ewing Sarcoma in the Metatarsal Bone After Chemotherapy: Report of a Case Successfully Treated with Pedicled Osteocutaneous Fibular Transfer.
Marais YA; Saini AK; Ferreira N; Reddy K; Zühlke A; Rossouw N; Zaharie SD; Schubert PT
Int J Surg Pathol; 2021 Oct; 29(7):798-803. PubMed ID: 33703949
[TBL] [Abstract] [Full Text] [Related]
4. Osteosarcoma and soft-tissue sarcomas with an immune infiltrate express PD-L1: relation to clinical outcome and Th1 pathway activation.
Wunder JS; Lee MJ; Nam J; Lau BY; Dickson BC; Pinnaduwage D; Bull SB; Ferguson PC; Seto A; Gokgoz N; Andrulis IL
Oncoimmunology; 2020 Mar; 9(1):1737385. PubMed ID: 33457085
[TBL] [Abstract] [Full Text] [Related]
5. clinical outcomes and survivals after total en bloc spondylectomy for metastatic leiomyosarcoma in the spine.
Kato S; Demura S; Shinmura K; Yokogawa N; Yonezawa N; Shimizu T; Oku N; Kitagawa R; Murakami H; Kawahara N; Tomita K; Tsuchiya H
Eur Spine J; 2020 Dec; 29(12):3237-3244. PubMed ID: 32424636
[TBL] [Abstract] [Full Text] [Related]
6. Leiomyosarcoma: Prognostic outline of a rare head and neck malignancy.
Saluja TS; Iyer J; Singh SK
Oral Oncol; 2019 Aug; 95():100-105. PubMed ID: 31345375
[TBL] [Abstract] [Full Text] [Related]
7. Pleomorphic Undifferentiated Uterine Sarcoma in a Young Patient Presenting With Elevated Beta-hCG and Rare Variants of Benign Leiomyoma: A Case Report and Review of the Literature.
Krishnan V; Sauthier P; Provencher D; Rahimi K
Int J Gynecol Pathol; 2020 Jul; 39(4):362-366. PubMed ID: 31033798
[TBL] [Abstract] [Full Text] [Related]
8. Establishment and proteomic characterization of NCC-lms1-C1, a novel cell line of primary leiomyosarcoma of the bone.
Sakumoto M; Takahashi M; Oyama R; Takai Y; Kito F; Shiozawa K; Qiao Z; Yoshida A; Endo M; Kawai A; Kondo T
Jpn J Clin Oncol; 2017 Oct; 47(10):954-961. PubMed ID: 28981730
[TBL] [Abstract] [Full Text] [Related]
9. The role of fibroblast growth factor 2 in patients with uterine smooth muscle tumors: an immunohistochemical study.
Bodner-Adler B; Mayerhofer K; Czerwenka K; Kimberger O; Koelbl H; Bodner K
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():62-67. PubMed ID: 27825029
[TBL] [Abstract] [Full Text] [Related]
10. Literature review of outcomes and prevalence and case report of leiomyosarcomas and non-typical uterine smooth muscle leiomyoma tumors treated with uterine artery embolization.
Kainsbak J; Hansen ES; Dueholm M
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():130-7. PubMed ID: 26117442
[TBL] [Abstract] [Full Text] [Related]
11. clinical outcome affected by tumor morcellation in unexpected early uterine leiomyosarcoma.
Lin KH; Torng PL; Tsai KH; Shih HJ; Chen CL
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):172-7. PubMed ID: 25951723
[TBL] [Abstract] [Full Text] [Related]
12. MRI, MDCT features, and clinical outcome of extremity leiomyosarcomas: experience in 47 patients.
Gordon RW; Tirumani SH; Kurra V; Shinagare AB; Jagannathan JP; Hornick JL; Ramaiya NH
Skeletal Radiol; 2014 May; 43(5):615-22. PubMed ID: 24496586
[TBL] [Abstract] [Full Text] [Related]
13. [Clinicopathologic features and prognostic factors of malignant phyllodes tumors].
Jia C; Mei F; Zheng J; You JF; Liu JY
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):729-34. PubMed ID: 24447548
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic role of E-cadherin and Vimentin expression in various subtypes of soft tissue leiomyosarcomas.
Tian W; Wang G; Yang J; Pan Y; Ma Y
Med Oncol; 2013 Mar; 30(1):401. PubMed ID: 23292832
[TBL] [Abstract] [Full Text] [Related]
15. ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.
Edris B; Espinosa I; Mühlenberg T; Mikels A; Lee CH; Steigen SE; Zhu S; Montgomery KD; Lazar AJ; Lev D; Fletcher JA; Beck AH; West RB; Nusse R; van de Rijn M
J Pathol; 2012 Jun; 227(2):223-33. PubMed ID: 22294416
[TBL] [Abstract] [Full Text] [Related]
16. CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis.
Espinosa I; Edris B; Lee CH; Cheng HW; Gilks CB; Wang Y; Montgomery KD; Varma S; Li R; Marinelli RJ; West RB; Nielsen T; Beck AH; van de Rijn M
Am J Pathol; 2011 Oct; 179(4):2100-7. PubMed ID: 21854753
[TBL] [Abstract] [Full Text] [Related]
17. clinical outcome of leiomyosarcomas of vascular origin: comparison with leiomyosarcomas of other origin.
Italiano A; Toulmonde M; Stoeckle E; Kind M; Kantor G; Coindre JM; Bui B
Ann Oncol; 2010 Sep; 21(9):1915-1921. PubMed ID: 20167595
[TBL] [Abstract] [Full Text] [Related]
18. Expression of E-cadherin, beta-catenin and topoisomerase IIalpha in leiomyosarcomas.
Gogou PN; Batistatou A; Pakos EE; Apostolikas N; Stefanou D; Tsekeris PG
Clin Transl Oncol; 2009 Aug; 11(8):548-51. PubMed ID: 19661031
[TBL] [Abstract] [Full Text] [Related]
19. The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors.
Atkins KA; Arronte N; Darus CJ; Rice LW
Am J Surg Pathol; 2008 Jan; 32(1):98-102. PubMed ID: 18162776
[TBL] [Abstract] [Full Text] [Related]
20. clinical outcome of metastatic uterine leiomyosarcoma and carcinosarcoma in a single institute.
Yoshinaga M; Togami S; Tsuji T; Fukamachi N; Kamio M; Yanagi M; Douchi T
J Obstet Gynaecol Res; 2007 Dec; 33(6):818-22. PubMed ID: 18001448
[TBL] [Abstract] [Full Text] [Related]
[Next]
